Skip to main content

Abstract

Vascular malformations are congenital lesions secondary to errors in the development of arteries, capillaries, veins, or lymphatics. The majority of these lesions are sporadic, however, a certain percentage can present with syndrome, which the treating physician should be aware of. These lesions are best treated from a multidisciplinary team comprising pediatricians, plastic surgeons, dermatologists, radiologists, otolaryngologists, and oral maxillary facial surgeons. Minimal invasive percutaneous therapies play a vital role in the treatment of vascular malformations, as a sole therapy of choice, or as an adjunct to surgery. Currently, a wide variety of embolic agents are utilized as seen in this chapter in the treatment of vascular malformations, however to date there are no published, randomized, control trials comparing the efficacy of the different agents. Further, animal and clinical studies are needed to help optimize the treatment for each type of vascular malformation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mulliken JB, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg. 1982;70(1):120–1.

    Article  CAS  PubMed  Google Scholar 

  2. Legiehn GM, Heran MK. Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin N Am. 2008;46(3):545–97, vi.

    Article  PubMed  Google Scholar 

  3. Tucci FM, De Vincentiis GC, Sitzia E, Giuzio L, Trozzi M, Bottero S. Head and neck vascular anomalies in children. Int J Pediatr Otorhinolaryngol. 2009;73 Suppl 1:S71–6.

    Article  PubMed  Google Scholar 

  4. Burrows PE, Mulliken JB, Fellows KE, Strand RD. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol. 1983;141(3):483–8.

    Article  CAS  PubMed  Google Scholar 

  5. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69(3):412–22.

    Article  CAS  PubMed  Google Scholar 

  6. Dompmartin A, Ballieux F, Thibon P, Lequerrec A, Hermans C, Clapuyt P, et al. Elevated D-dimer level in the differential diagnosis of venous malformations. Arch Dermatol. 2009;145(11):1239–44.

    Article  CAS  PubMed  Google Scholar 

  7. Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet. 2007;16 Spec No. 2:R140–9.

    Article  CAS  PubMed  Google Scholar 

  8. Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet. 1994;3(9):1583–7.

    Article  CAS  PubMed  Google Scholar 

  9. Gallione CJ, Pasyk KA, Boon LM, Lennon F, Johnson DW, Helmbold EA, et al. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet. 1995;32(3):197–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996;87(7):1181–90.

    Article  CAS  PubMed  Google Scholar 

  11. Calvert JT, Riney TJ, Kontos CD, Cha EH, Prieto VG, Shea CR, et al. Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet. 1999;8(7):1279–89.

    Article  CAS  PubMed  Google Scholar 

  12. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004;15(5):431–45.

    Article  PubMed  Google Scholar 

  13. Trop I, Dubois J, Guibaud L, Grignon A, Patriquin H, McCuaig C, et al. Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology. 1999;212(3):841–5.

    Article  CAS  PubMed  Google Scholar 

  14. Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics. 2001;21(6):1519–31.

    Article  CAS  PubMed  Google Scholar 

  15. Moukaddam H, Pollak J, Haims AH. MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol. 2009;38(6):535–47.

    Article  PubMed  Google Scholar 

  16. Fayad LM, Hazirolan T, Carrino JA, Bluemke DA, Mitchell S. Venous malformations: MR imaging features that predict skin burns after percutaneous alcohol embolization procedures. Skeletal Radiol. 2008;37(10):895–901.

    Article  PubMed  Google Scholar 

  17. van Rijswijk CS, van der Linden E, van der Woude HJ, van Baalen JM, Bloem JL. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations. AJR Am J Roentgenol. 2002;178(5):1181–7.

    Article  PubMed  Google Scholar 

  18. Puig S, Casati B, Staudenherz A, Paya K. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol. 2005;53(1):35–45.

    Article  PubMed  Google Scholar 

  19. Dubois JM, Sebag GH, De Prost Y, Teillac D, Chretien B, Brunelle FO. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. Radiology. 1991;180(1):195–8.

    Article  CAS  PubMed  Google Scholar 

  20. Puig S, Aref H, Chigot V, Bonin B, Brunelle F. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol. 2003;33(2):99–103.

    Article  PubMed  Google Scholar 

  21. Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int. 2004;19(12):766–73.

    Article  CAS  PubMed  Google Scholar 

  22. Lee BB. New approaches to the treatment of congenital vascular malformations (CVMs)–a single centre experience. Eur J Vasc Endovasc Surg. 2005;30(2):184–97.

    Article  CAS  PubMed  Google Scholar 

  23. O’Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol. 1997;169(3):723–9.

    Article  PubMed  Google Scholar 

  24. Chen Y, Li Y, Zhu Q, Zeng Q, Zhao J, He X, et al. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations. AJR Am J Roentgenol. 2008;190(4):966–71.

    Article  PubMed  Google Scholar 

  25. Wallace MJ, Kuo MD, Glaiberman C, Binkert CA, Orth RC, Soulez G. Three-dimensional C-arm cone-beam CT: applications in the interventional suite. J Vasc Interv Radiol. 2008;19(6):799–813.

    Article  PubMed  Google Scholar 

  26. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999;104(1):1–11; discussion 2–5.

    Article  CAS  PubMed  Google Scholar 

  27. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg. 2003;37(3):533–8.

    Article  CAS  PubMed  Google Scholar 

  28. Mason KP, Neufeld EJ, Karian VE, Zurakowski D, Koka BV, Burrows PE. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies. AJR Am J Roentgenol. 2001;177(6):1359–63.

    Article  CAS  PubMed  Google Scholar 

  29. Wong GA, Armstrong DC, Robertson JM. Cardiovascular collapse during ethanol sclerotherapy in a pediatric patient. Paediatr Anaesth. 2006;16(3):343–6.

    Article  CAS  PubMed  Google Scholar 

  30. Donnelly LF, Bisset GS 3rd, Adams DM. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect. Pediatr Radiol. 2000;30(6):415–9.

    Article  CAS  PubMed  Google Scholar 

  31. Anadon MJ, Almendral J, Gonzalez P, Zaballos M, Delcan JL, De Guevara JL. Alcohol concentration determines the type of atrial arrhythmia induced in a porcine model of acute alcoholic intoxication. Pacing and clinical electrophysiology. PACE. 1996;19(11 Pt 2):1962–7.

    Article  CAS  PubMed  Google Scholar 

  32. Chi LM, Wu WG. Mechanism of hemolysis of red blood cell mediated by ethanol. Biochim Biophys Acta. 1991;1062(1):46–50.

    Article  CAS  PubMed  Google Scholar 

  33. Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity. Anesth Analg. 1995;80(2):415–7.

    CAS  PubMed  Google Scholar 

  34. Hammer FD, Boon LM, Mathurin P, Vanwijck RR. Ethanol sclerotherapy of venous malformations: evaluation of systemic ethanol contamination. J Vasc Interv Radiol. 2001;12(5):595–600.

    Article  CAS  PubMed  Google Scholar 

  35. Mason KP, Michna E, Zurakowski D, Koka BV, Burrows PE. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies. Radiology. 2000;217(1):127–32.

    Article  CAS  PubMed  Google Scholar 

  36. Su L, Fan X, Zheng L, Zheng J. Absolute ethanol sclerotherapy for venous malformations in the face and neck. J Oral Maxillofacial Surg Off J Am Assoc Oral Maxillofacial Surg. 2010;68(7):1622–7.

    Article  Google Scholar 

  37. Yun WS, Kim YW, Lee KB, Kim DI, Park KB, Kim KH, et al. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg. 2009;50(3):581–9, 9 e1.

    Article  PubMed  Google Scholar 

  38. Lee IH, Kim KH, Jeon P, Byun HS, Kim HJ, Kim ST, et al. Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results. Korean J Radiol. 2009;10(3):269–76.

    Article  PubMed  PubMed Central  Google Scholar 

  39. de Lorimier AA. Sclerotherapy for venous malformations. Journal of pediatric surgery. 1995;30(2):188–93; discussion 94.

    Article  PubMed  Google Scholar 

  40. Gelbert F, Enjolras O, Deffrenne D, Aymard A, Mounayer C, Merland JJ. Percutaneous sclerotherapy for venous malformation of the lips: a retrospective study of 23 patients. Neuroradiology. 2000;42(9):692–6.

    Article  CAS  PubMed  Google Scholar 

  41. Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edstrom S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg. 1997;31(2):145–50.

    Article  CAS  PubMed  Google Scholar 

  42. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol. 2001;20(4):322–9.

    CAS  PubMed  Google Scholar 

  43. Yamaki T, Nozaki M, Fujiwara O, Yoshida E. Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face. Dermatol Surg Off Publ Am SocDermatol Surg [et al]. 2002;28(7):619–22.

    Google Scholar 

  44. Choi DJ, Alomari AI, Chaudry G, Orbach DB. Neurointerventional management of low-flow vascular malformations of the head and neck. Neuroimaging Clin N Am. 2009;19(2):199–218.

    Article  PubMed  Google Scholar 

  45. Hussar DA, Stevenson T. New drugs: Denosumab, dienogest/estradiol valerate, and polidocanol. J Am Pharm Assoc (Wash DC). 2010;50(5):658–62.

    Article  Google Scholar 

  46. Marrocco-Trischitta MM, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg Off Publ Am SocDermatol Surg [et al]. 2002;28(2):153–5.

    Google Scholar 

  47. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg Off Publ Am SocDermatol Surg [et al]. 2001;27(1):58–60.

    CAS  Google Scholar 

  48. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg. 2008;47(3):578–84.

    Article  PubMed  Google Scholar 

  49. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139(11):1409–16.

    Article  PubMed  Google Scholar 

  50. Kaji N, Kurita M, Ozaki M, Takushima A, Harii K, Narushima M, et al. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck. Scand J Plast Reconstr Surg Hand Surg. 2009;43(3):126–36.

    Article  PubMed  Google Scholar 

  51. Spence J, Krings T, terBrugge KG, da Costa LB, Agid R. Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. AJNR Am J Neuroradiol. 2010;31(5):955–60.

    Article  CAS  PubMed  Google Scholar 

  52. Lacey B, Rootman J, Marotta TR. Distensible venous malformations of the orbit: clinical and hemodynamic features and a new technique of management. Ophthalmology. 1999;106(6):1197–209.

    Article  CAS  PubMed  Google Scholar 

  53. Sidhu MK, Perkins JA, Shaw DW, Bittles MA, Andrews RT. Ultrasound-guided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience. J Vasc Interv Radiol. 2005;16(6):879–84.

    Article  PubMed  Google Scholar 

  54. Werner JA, Lippert BM, Gottschlich S, Folz BJ, Fleiner B, Hoeft S, et al. Ultrasound-guided interstitial Nd: YAG laser treatment of voluminous hemangiomas and vascular malformations in 92 patients. Laryngoscope. 1998;108(4 Pt 1):463–70.

    Article  CAS  PubMed  Google Scholar 

  55. Chang CJ, Fisher DM, Chen YR. Intralesional photocoagulation of vascular anomalies of the tongue. Br J Plast Surg. 1999;52(3):178–81.

    Article  CAS  PubMed  Google Scholar 

  56. Vesnaver A, Dovsak DA. Treatment of vascular lesions in the head and neck using Nd:YAG laser. J Craniomaxillofac Surg. 2006;34(1):17–24.

    Article  PubMed  Google Scholar 

  57. Scherer K, Waner M. Nd:YAG lasers (1,064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits. Lasers Med Sci. 2007;22(2):119–26.

    Article  PubMed  Google Scholar 

  58. Sarig O, Kimel S, Orenstein A. Laser treatment of venous malformations. Ann Plast Surg. 2006;57(1):20–4.

    Article  CAS  PubMed  Google Scholar 

  59. Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol. 1993;10(4):311–3.

    Article  CAS  PubMed  Google Scholar 

  60. Burrows PE, Fellows KE. Techniques for management of pediatric vascular anomalies. In: Current techniques in interventional radiology. Philadelphia: McGraw-Hill Professional; 1995. pp. 11–7.

    Google Scholar 

  61. Al-Adnani M, Williams S, Rampling D, Ashworth M, Malone M, Sebire NJ. Histopathological reporting of paediatric cutaneous vascular anomalies in relation to proposed multidisciplinary classification system. J Clin Pathol. 2006;59(12):1278–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. North PE, Waner M, Buckmiller L, James CA, Mihm MC Jr. Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol. 2006;15(6):303–17.

    Article  PubMed  Google Scholar 

  63. Smith RJ. Lymphatic malformations. Lymphat Res Biol. 2004;2(1):25–31.

    Article  PubMed  Google Scholar 

  64. Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds JL Jr, Hoffer FA, et al. Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 2010;142(6):795–803, e1.

    Article  Google Scholar 

  65. de Serres LM, Sie KC, Richardson MA. Lymphatic malformations of the head and neck. A proposal for staging. Arch Otolaryngol Head Neck Surg. 1995;121(5):577–82.

    Article  PubMed  Google Scholar 

  66. Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope. 2009;119(1):107–15.

    Article  CAS  PubMed  Google Scholar 

  67. Abernethy LJ. Classification and imaging of vascular malformations in children. Eur Radiol. 2003;13(11):2483–97.

    Article  PubMed  Google Scholar 

  68. Dubois J, Alison M. Vascular anomalies: what a radiologist needs to know. Pediatr Radiol. 2010;40(6):895–905.

    Article  PubMed  Google Scholar 

  69. Dubois J, Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol. 1999;29(12):879–93.

    Article  CAS  PubMed  Google Scholar 

  70. Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin. 1998;16(3):455–88.

    Article  CAS  PubMed  Google Scholar 

  71. Mathur NN, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol. 2005;69(1):75–80.

    Article  PubMed  Google Scholar 

  72. Shiels WE 2nd, Kenney BD, Caniano DA, Besner GE. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg. 2008;43(1):136–9, discussion 40.

    Article  PubMed  Google Scholar 

  73. Shiels WE 2nd, Kang DR, Murakami JW, Hogan MJ, Wiet GJ. Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 2009;141(2):219–24.

    Article  Google Scholar 

  74. Okazaki T, Iwatani S, Yanai T, Kobayashi H, Kato Y, Marusasa T, et al. Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg. 2007;42(2):386–9.

    Article  PubMed  Google Scholar 

  75. Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology. 1997;204(3):651–4.

    Article  CAS  PubMed  Google Scholar 

  76. Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol. 2006;17(10):1639–48.

    Article  PubMed  Google Scholar 

  77. Cahill AM, Nijs EL. Pediatric vascular malformations: pathophysiology, diagnosis, and the role of interventional radiology. Cardiovasc Intervent Radiol. 2011;34(4):691–704.

    Article  PubMed  Google Scholar 

  78. Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg. 2008;43(3):451–60.

    Article  PubMed  Google Scholar 

  79. Svendsen PA, Wikholm G, Rodriguez M, Enoksson P, Frisen L, Stromland K, et al. Direct puncture and sclerotherapy with sotradecol ((r)). Orbital lymphatic malformations. Interv Neuroradiol J Perith Neuroradiol Surg Proced Relat Neurosci. 2001;7(3):193–9.

    CAS  Google Scholar 

  80. Ogita S, Tsuto T, Tokiwa K, Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg. 1987;74(8):690–1.

    Article  CAS  PubMed  Google Scholar 

  81. Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N. OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg. 1996;31(4):477–80.

    Article  CAS  PubMed  Google Scholar 

  82. Ohta N, Fukase S, Watanabe T, Ito T, Aoyagi M. Effects and mechanism of OK-432 therapy in various neck cystic lesions. Acta Otolaryngol. 2010;130(11):1287–92.

    Article  CAS  PubMed  Google Scholar 

  83. Poldervaart MT, Breugem CC, Speleman L, Pasmans S. Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature. J Craniofac Surg. 2009;20(4):1159–62.

    Article  PubMed  Google Scholar 

  84. Yoo JC, Ahn Y, Lim YS, Hah JH, Kwon TK, Sung MW, et al. OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 2009;140(1):120–3.

    Article  Google Scholar 

  85. Emran MA, Dubois J, Laberge L, Al-Jazaeri A, Butter A, Yazbeck S. Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children. J Pediatr Surg. 2006;41(5):975–9.

    Article  PubMed  Google Scholar 

  86. Niramis R, Watanatittan S, Rattanasuwan T. Treatment of cystic hygroma by intralesional bleomycin injection: experience in 70 patients. Eur J Pediatr Surg Off J Austrian Assoc Pediatr Surg [et al]= Z Kinderchir. 2010;20(3):178–82.

    CAS  Google Scholar 

  87. Zhong PQ, Zhi FX, Li R, Xue JL, Shu GY. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86(2):139–44.

    Article  CAS  PubMed  Google Scholar 

  88. Wiegand S, Eivazi B, Zimmermann AP, Neff A, Barth PJ, Sesterhenn AM, et al. Microcystic lymphatic malformations of the tongue: diagnosis, classification, and treatment. Arch Otolaryngol Head Neck Surg. 2009;135(10):976–83.

    Article  PubMed  Google Scholar 

  89. Grimmer JF, Mulliken JB, Burrows PE, Rahbar R. Radiofrequency ablation of microcystic lymphatic malformation in the oral cavity. Arch Otolaryngol Head Neck Surg. 2006;132(11):1251–6.

    Article  PubMed  Google Scholar 

  90. Elluru RG, Azizkhan RG. Cervicofacial vascular anomalies. II. Vascular malformations. Semin Pediatr Surg. 2006;15(2):133–9.

    Article  PubMed  Google Scholar 

  91. Geronemus RG, Ashinoff R. The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol. 1991;17(1):76–9.

    Article  CAS  PubMed  Google Scholar 

  92. Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. 2003;73(6):1240–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Frech M, John J, Pizon V, Chardin P, Tavitian A, Clark R, et al. Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. Science. 1990;249(4965):169–71.

    Article  CAS  PubMed  Google Scholar 

  94. Tallman B, Tan OT, Morelli JG, Piepenbrink J, Stafford TJ, Trainor S, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics. 1991;87(3):323–7.

    CAS  PubMed  Google Scholar 

  95. Geronemus RG, Quintana AT, Lou WW, Kauvar AN. High-fluence modified pulsed dye laser photocoagulation with dynamic cooling of port-wine stains in infancy. Arch Dermatol. 2000;136(7):942–3.

    Article  CAS  PubMed  Google Scholar 

  96. van der Horst CM, Koster PH, de Borgie CA, Bossuyt PM, van Gemert MJ. Effect of the timing of treatment of port-wine stains with the flash-lamp-pumped pulsed-dye laser. N Engl J Med. 1998;338(15):1028–33.

    Article  PubMed  Google Scholar 

  97. Cordoro KM, Speetzen LS, Koerper MA, Frieden IJ. Physiologic changes in vascular birthmarks during early infancy: Mechanisms and clinical implications. J Am Acad Dermatol. 2009;60(4):669–75.

    Article  PubMed  Google Scholar 

  98. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375–423.

    CAS  PubMed  Google Scholar 

  99. Srinivasa RN, Burrows PE. Dural arteriovenous malformation in a child with Bannayan-Riley-Ruvalcaba Syndrome. AJNR Am J Neuroradiol. 2006;27(9):1927–9.

    CAS  PubMed  Google Scholar 

  100. Naidich JJ, Rofsky NM, Rosen R, Karp N. Arteriovenous malformation in a patient with Bannayan–Zonana syndrome. Clin Imaging. 2001;25(2):130–2.

    Article  CAS  PubMed  Google Scholar 

  101. Tan WH, Baris HN, Burrows PE, Robson CD, Alomari AI, Mulliken JB, et al. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet. 2007;44(9):594–602.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Seki T, Yun J, Oh SP. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res. 2003;93(7):682–9.

    Article  CAS  PubMed  Google Scholar 

  103. Taschner CA, Gieseke J, Thuc V L, Rachdi H, Reyns N, Gauvrit JY, et al. Intracranial arteriovenous malformation: time-resolved contrast-enhanced MR angiography with combination of parallel imaging, keyhole acquisition, and k-space sampling techniques at 1.5 T. Radiology. 2008;246(3):871–9.

    Article  PubMed  Google Scholar 

  104. Cho SK, Do YS, Shin SW, Kim DI, Kim YW, Park KB, et al. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther. 2006;13(4):527–38.

    Article  PubMed  Google Scholar 

  105. Shin BS, Do YS, Lee BB, Kim DI, Chung IS, Cho HS, et al. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure. Radiology. 2005;235(3):1072–7.

    Article  PubMed  Google Scholar 

  106. Do YS, Park KB, Park HS, Cho SK, Shin SW, Moon JW, et al. Extremity arteriovenous malformations involving the bone: therapeutic outcomes of ethanol embolotherapy. J Vasc Interv Radiol. 2010;21(6):807–16.

    Article  PubMed  Google Scholar 

  107. Yakes WF, Rossi P, Odink H. How I do it. Arteriovenous malformation management. Cardiovasc Intervent Radiol. 1996;19(2):65–71.

    Article  CAS  PubMed  Google Scholar 

  108. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol. 2002;23(5):748–55.

    Google Scholar 

  109. Pollak JS, White RI Jr. The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol. 2001;12(8):907–13.

    Article  CAS  PubMed  Google Scholar 

  110. De Luca D, Piastra M, Pietrini D, Rollo M, Conti G. “Glue lung”: pulmonary micro-embolism caused by the glue used during interventional radiology. Arch Dis Child. 2008;93(3):263.

    Article  PubMed  Google Scholar 

  111. Arat A, Cil BE, Vargel I, Turkbey B, Canyigit M, Peynircioglu B, et al. Embolization of high-flow craniofacial vascular malformations with onyx. AJNR Am J Neuroradiol. 2007;28(7):1409–14.

    Article  CAS  PubMed  Google Scholar 

  112. Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M, Wanke I. Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol. 2009;30(1):99–106.

    Article  CAS  PubMed  Google Scholar 

  113. Loh Y, Duckwiler GR. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 2010;113(4):733–41.

    Article  PubMed  Google Scholar 

  114. Pollock BE, Flickinger JC, Lunsford LD, Maitz A, Kondziolka D. Factors associated with successful arteriovenous malformation radiosurgery. Neurosurgery. 1998;42(6):1239–44, discussion 44–7.

    Article  CAS  PubMed  Google Scholar 

  115. Pollock BE, Gorman DA, Coffey RJ. Patient outcomes after arteriovenous malformation radiosurgical management: results based on a 5- to 14-year follow-up study. Neurosurgery. 2003;52(6):1291–6, discussion 6–7.

    Article  PubMed  Google Scholar 

  116. Friedman WA. Radiosurgery versus surgery for arteriovenous malformations: the case for radiosurgery. Clin Neurosurg. 1999;45:18–20.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph J. Gemmete MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gemmete, J., Vellody, R. (2016). Sclerotherapy of Vascular Malformations. In: Scholz, S., Jarboe, M. (eds) Diagnostic and Interventional Ultrasound in Pediatrics and Pediatric Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-21699-7_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-21699-7_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-21698-0

  • Online ISBN: 978-3-319-21699-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics